YE Table 1 (cont'd) Est. Pt. No. & sex Age 1979 thyroid dose (rads) Thyroid Nodularities Age at detection Surgery Hypofunction Diagnosis TSH (w/d1) (c)} Rongelap exposed at age >18 18 F 45 335 4M 63 335 64 F 55 335 78 F 62 335 66 F 55 335 71 F 34 F 52 70 335 335 34 41 Cleve. '69 Bost. '65 Papillary Ca Papillary Ca 6.0, 7.0 6.6, 8.8 55 Cleve. '79 Adenomatous nod. Cleve. ‘72 Cleve. '81 Adenomatous nod. Occult Pap. Ca 6.5, 7.0 6.3, 8.3 (d) Ailingnae exposed at age <10 8F 53 F 26 33 450 320 18 28 (e) Ailingnae exposed at age 10-18: and adenomatous nod. NONE (£) Ailingnae exposed at age >18 51 F 50 135 45 F 57 135 59 F _— 135 16 M 64 41 M 69 135 45 Cleve. ‘74 51 Cleve. '73 53 Bost. '66 135 Adenoma Adenomatcous nod. Nodule Adenomatous nod. (died '68, age 54) 6.4, 6.5 (g) Utirik exposed at age <10 2160 F 2154 F 31 29 80 75 28 25 Cleve. ‘75 2147 F 2239 F 26 28 90 80 25 28 Cleve. ‘79 Cleve. ‘81 2132 F 27 80 27 Cleve. ‘81 Papillary Ca Nodule reduced ‘79 Adenomatous nod. " " " " (h) Utirik exposed at age 10-18 2150 M 2229 F 37 43 54 31 33 32 Cleve. ‘76 Cleve. ‘69 2236 M 36 55 34 Hono. ‘78 - 126 + Adenoma Papillary Ca vs. atypical adenoma Adenoma